In response to the Letter to the Editor by Romach et al. re our publication “Dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels”

In response to the Letter to the Editor by Romach et al. re our publication “Dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels”

Bibliographic Details
Main Authors: H. Mohan, M. Guzman Lenis, E.Y. Laurette, O. Tejada, T. Sanghvi, K.-Y. Leung, L.S. Cahill, J.G. Sled, P. Delgado-Olguín, N.D.E. Greene, A.J. Copp, L. Serghides
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:EBioMedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396421001274

Internet

http://www.sciencedirect.com/science/article/pii/S2352396421001274

Similar Items